Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADHERIUM LIMITED Director's Dealing 2024

Apr 3, 2024

64305_rns_2024-04-03_7eeee710-95c9-4770-a2e2-bdadd57cb311.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Adherium Limited ABN 24 605 352 510

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director George Baran
Date of last notice 13 December 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
Trudell Medical Limited
-
Mr Baran has a 33.33% beneficial interest in Trudell Medical
Limited
Date of change 31 March 2024
No. of securities held prior to
change
(post security consolidation on
1 for 15 basis in December
2023)
-
73,538,685 Fully paid ordinary shares
-
22,666,667 Options over fully paid ordinary shares, exercisable at
$0.15 each and expiring on 31 March 2024
-
699,064 Options over fully paid ordinary shares, exercisable at
$0.3285 each and expiring on 29 January 2027
Class Options over fully paid ordinary shares, exercisable at $0.15 each and
expiring on 31 March 2024
Number acquired -
Number disposed 22,666,667
Value/Consideration
Note: If consideration is non-cash, provide
details and estimated valuation
Nil – lapse on expiry
No. of securities held after
change
-
73,538,685 Fully paid ordinary shares
-
699,064 Options over fully paid ordinary shares, exercisable at
$0.3285 each and expiring on 29 January 2027
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Expiry of unlisted options on 31 March 2024 Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a
contract in relation to which the interest
has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash,
provide details and an estimated
valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance
was required?
No.
If so, was prior written clearance provided to allow the trade
to proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Adherium Limited ABN 24 605 352 510

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Louis Panaccio
Date of last notice 4 November 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
Vilmos Pty Ltd as trustee for the Panaccio Investment Trust
Date of change 31 March 2024
No. of securities held prior to
change
(post security consolidation on
1 for 15 basis in December
2023)
-
1,333,334 Fully paid ordinary shares
-
666,667 Options over fully paid ordinary shares, exercisable at
$0.15 each and expiring on 31 March 2024
Class Options over fully paid ordinary shares, exercisable at $0.15 each and
expiring on 31 March 2024
Number acquired -
Number disposed 666,667
Value/Consideration
Note: If consideration is non-cash, provide
details and estimated valuation
Nil – lapse on expiry
No. of securities held after
change
1,333,334 Fully paid ordinary shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Expiry of unlisted options on 31 March 2024 Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a
contract in relation to which the interest
has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash,
provide details and an estimated
valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance
was required?
No.
If so, was prior written clearance provided to allow the trade
to proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011